发明名称 USES OF MITO-OB TRANSGENIC MICE
摘要 The Mito-Ob obese mouse model overexpresses the mitochondrial protein prohibitin (PHB). Mito-Ob male mice develop insulin resistance in addition to obesity and they do not develop overt diabetes. It has been discovered that these mice also spontaneously develop nonalcoholic steatohepatitis (NASH) and hepatocarcinogenesis over time. Also described is a mutant Mito-Ob mouse that develops lymphadenopathy and histiocytosis.
申请公布号 US2017089888(A1) 申请公布日期 2017.03.30
申请号 US201615278820 申请日期 2016.09.28
申请人 University of Manitoba 发明人 Ande Sudharsana Rao;Nguyen Khanh Hoa;Mishra Suresh
分类号 G01N33/50;A01K67/027 主分类号 G01N33/50
代理机构 代理人
主权项 1. A method of determining if a compound of interest reduces severity of non-alcoholic steatohepatitis and/or hepatocellular carcinoma comprising: growing a transgenic mouse overexpressing the mitochondrial protein prohibitin (PHB) to approximately at least 3 months of age, wherein the PHB gene is operably linked to the adipocyte protein 2 (aP2) promoter; administering the compound of interest to the transgenic mouse; and determining if the compound of interest delays onset or reduces severity of non-alcoholic steatohepatitis and/or hepatocellular carcinoma.
地址 Winnipeg CA